# OnCo record nct06776952 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct06776952/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct06776952", "NCT06776952" ;
  schema:name "A Randomized, Double-blind, Multicenter Phase III Study of XNW5004 Tablets in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma"@en ;
  schema:description "A phase 3 trial of Tucidinostat (chidamide) and XNW5004 in peripheral T-cell lymphomas, run by Evopoint Biosciences Inc., now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct06776952/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06776952> ;
  onco:status "recruiting" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "3" ;
  schema:startDate "2025-04-10" ;
  onco:cancers <https://onco.cc/cancers/peripheral-t-cell-lymphoma/> ;
  onco:drugs <https://onco.cc/drugs/tucidinostat/>, <https://onco.cc/drugs/xnw5004/> ;
  onco:companies <https://onco.cc/companies/evopoint-biosciences/> .